Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Trial and a Phase 2 Kidney Trial is Planned for 2017**

Free
AGORACOM NEWS FLASH

BREAKING NEWS!!!

Namaste Enters Into Non-Binding LOI With CannMart, a Late Stage ACMPR Applicant

  • Namaste will purchase all of the issued and outstanding shares in the capital of CannMart, a late stage applicant under the Access to Cannabis for Medical Purposes Regulations
  • CannMart submitted its application to become a “sales only” licensed producer of medical cannabis

Nlogo

Hub On AGORACOM/ Read Release 

Message: Cowen presentation significance

Hi all,

 

Been a while. Although I have not been posting, I have been following (and neither have I sold a single one of my shares). Thank you for some of the excellent posting you have been doing with special mention to Bear and BKC - we are lucky to have 2 such high quality fellow shareholders.

 

Perhaps I missed it, but has anyone remarked on the significance of the Cowen presentation? Cowen is a proper shop. I find it interesting (and potentially very positive) that RVX presented at their conf. To me it increases the likelihood that RVX is going to do a proper bit of investor marketing and fund raising. If so this would likely involve a significant ramp in the shareprice. This could serve to clear the LOC. Either way I don't lose too much sleep over the LOC overhang - the shares are grossly undervalued even with full LOC dilution if a placing was done at these levels.

I thought the Cowen presentation looked like a good one. The most investor focused one I have seen to date.

All the best

Tundup

Share
New Message
Please login to post a reply